Dynamic Technology Lab’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-59,278
Closed -$633K 1061
2024
Q3
$633K Sell
59,278
-11,053
-16% -$120K 0.07% 485
2024
Q2
$698K Buy
70,331
+26,333
+60% +$270K 0.08% 408
2024
Q1
$518K Buy
+43,998
New +$563K 0.06% 587
2023
Q2
Sell
-32,307
Closed -$358K 1125
2023
Q1
$358K Buy
32,307
+7,596
+31% +$93.6K 0.03% 739
2022
Q4
$302K Sell
24,711
-9,909
-29% -$112K 0.03% 775
2022
Q3
$361K Buy
+34,620
New +$386K 0.04% 740
2021
Q4
Sell
-72,282
Closed -$690K 1245
2021
Q3
$690K Buy
+72,282
New +$739K 0.08% 417
2020
Q1
Sell
-26,680
Closed -$260K 1141
2019
Q4
$260K Sell
26,680
-9,381
-26% -$85.9K 0.04% 735
2019
Q3
$289K Buy
36,061
+11,113
+45% +$121K 0.05% 676
2019
Q2
$311K Buy
+24,948
New +$317K 0.05% 623
2018
Q4
Sell
-14,256
Closed -$172K 1077
2018
Q3
$172K Buy
+14,256
New +$199K 0.02% 911
2016
Q3
Sell
-19,842
Closed -$108K 966
2016
Q2
$108K Buy
+19,842
New +$139K 0.03% 794
2014
Q4
Sell
-22,667
Closed -$136K 725
2014
Q3
$136K Buy
+22,667
New +$119K 0.07% 551
2013
Q4
Sell
-11,839
Closed -$28K 586
2013
Q3
$28K Buy
+11,839
New +$29.7K 0.02% 450

Other funds holding FOLD

Dynamic Technology Lab's FOLD Position: Q4 2024 in Review

Dynamic Technology Lab sold out of Amicus Therapeutics (FOLD) in Q4 2024, closing a stake of 59,278 shares — an estimated $633K sold.

Dynamic Technology Lab first reported a position in FOLD in Q3 2013 and held it in 14 quarters. The position peaked at $698K in Q2 2024. 290 funds tracked by Wall St. Rank hold FOLD as of Q4 2024.

  • Dynamic Technology Lab reported no remaining Amicus Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 59,278 Amicus Therapeutics shares in Q4 2024, an estimated $633K.
  • Dynamic Technology Lab first reported a position in Amicus Therapeutics in Q3 2013 and held it in 14 quarters.
  • Dynamic Technology Lab's Amicus Therapeutics position peaked at $698K in Q2 2024.
  • 290 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2024.

Based on Dynamic Technology Lab's 13F filing for Q4 2024, filed 13 Feb 2025.